Bentham Science Logo

Track Your Manuscript:


Drug Metabolism Letters

Volume 14, 3 Issues, 2020
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Drug Metabolism Letters, Volume 6 - Number 1



Molecular Analysis and Modeling of Inactivation of Human CYP2D6 by Four Mechanism Based Inactivators

, 6(1): 7 - 14

Mara Livezey, Leslie D. Nagy, Laura E. Diffenderfer, Evan J. Arthur, David J. Hsi, Jeffrey M. Holton and Laura Lowe Furge


DOI: 10.2174/187231212800229318



Loxapine P-glycoprotein Interactions In Vitro

, 6(1): 26 - 32

Andrea Reed, Keith Huie, Elke S. Perloff, James V. Cassella and Lori H. Takahashi


DOI: 10.2174/187231212800229255


Preclinical Metabolism and Pharmacokinetics of SB1317 (TG02), a Potent CDK/JAK2/FLT3 Inhibitor

, 6(1): 33 - 42

Mohammed Khalid Pasha, Ramesh Jayaraman, Venkatesh Pilla Reddy, Pauline Yeo, Evelyn Goh, Anthony Williams, Kee Chuan Goh and Ethirajulu Kantharaj


DOI: 10.2174/187231212800229336






Editor-in-Chief

Zhiyang Zhao
Alliance Pharma
Malvern, PA
(USA)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Drug Metabolism Letters was launched in 2007. Dr. Zhiyang Zhao serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.01

Advertisement

PLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog